Cargando…
Pembrolizumab: Immune-mediated pancreatitis: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099262/ http://dx.doi.org/10.1007/s40278-022-15217-6 |
Ejemplares similares
-
Pembrolizumab: Autoimmune haemolytic anaemia and immune-mediated colitis: case report
Publicado: (2021) -
Pembrolizumab‐related pancreatitis with elevation of pancreatic tumour markers
por: Kakuwa, Tamaki, et al.
Publicado: (2020) -
Pembrolizumab: Various toxicities: case report
Publicado: (2021) -
Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series
por: Zhao, Li, et al.
Publicado: (2022) -
Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report
por: Tanaka, Takeshi, et al.
Publicado: (2022)